Aristo Bio-Tech and Lifescience Ltd. - Research Center
Group () BSE data
Results
Statement
More
Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Mar ' 20 |
Mar ' 19 |
Equity share capital
Share application money
Preference share capital
Reserves & surplus
23.35 |
9.85 |
8.39 |
7.38 |
6.41 |
Secured loans
22.49 |
25.48 |
22.25 |
18.27 |
14.45 |
Unsecured loans
Total
52.65 |
40.33 |
35.63 |
30.64 |
25.85 |
Gross block
22.73 |
19.94 |
16.88 |
12.07 |
5.98 |
Less : revaluation reserve
Less : accumulated depreciation
Net block
15.62 |
14.36 |
12.31 |
8.25 |
2.69 |
Capital work-in-progress
Investments
Current assets, loans & advances
83.11 |
62.54 |
69.10 |
76.84 |
81.17 |
Less : current liabilities & provisions
47.18 |
36.67 |
45.79 |
57.28 |
64.85 |
Total net current assets
35.93 |
25.87 |
23.31 |
19.57 |
16.33 |
Miscellaneous expenses not written
Total
52.65 |
40.33 |
35.63 |
30.64 |
25.85 |
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
Number of equity sharesoutstanding (Lacs)
68.08 |
49.95 |
49.95 |
49.95 |
49.95 |